C-MER Medical Holdings Limited disclosed that it repurchased 148,000 ordinary shares on-market on 8 July 2026 at prices ranging between HKD 0.99 and HKD 1.00, for a total consideration of HKD 0.15 million.

The transaction represents 0.0122 % of the company’s 1.21 billion issued shares (excluding treasury shares) outstanding prior to the buyback. All repurchased shares have been retained as treasury shares, lifting the treasury share balance to 21.28 million and trimming the free-float share count to 1.21 billion.

The buyback is the first utilisation of the mandate approved by shareholders on 20 May 2026, which authorises C-MER Medical to repurchase up to 123.23 million shares. To date, 0.012 % of that limit has been used. In accordance with Hong Kong Stock Exchange rules, the company is subject to a moratorium on issuing new shares or selling treasury shares until 7 August 2026.